[1]
A. Bregenzer, “Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade”, Swiss Med Wkly, vol. 147, no. 4748, p. w14544, Nov. 2017.